Peoples Bank (Kansas)’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-30
Closed -$5.82K – 320
2024
Q3
$5.82K Hold
30
– – ﹤0.01% 274
2024
Q2
$6.95K Hold
30
– – 0.01% 233
2024
Q1
$6.47K Hold
30
– – 0.01% 233
2023
Q4
$7.76K Hold
30
– – 0.01% 220
2023
Q3
$7.71K Buy
+30
New +$8.02K 0.01% 216

Other funds holding BIIB

Peoples Bank (Kansas)'s BIIB Position: Q4 2024 in Review

Peoples Bank (Kansas) sold out of Biogen (BIIB) in Q4 2024, closing a stake of 30 shares — an estimated $5.82K sold.

Peoples Bank (Kansas) first reported a position in BIIB in Q3 2023 and held it in 5 quarters. The position peaked at $7.76K in Q4 2023. 876 funds tracked by Wall St. Rank hold BIIB as of Q4 2024.

  • Peoples Bank (Kansas) reported no remaining Biogen position as of Q4 2024 after selling out during the quarter.
  • Peoples Bank (Kansas) sold 30 Biogen shares in Q4 2024, an estimated $5.82K.
  • Peoples Bank (Kansas) first reported a position in Biogen in Q3 2023 and held it in 5 quarters.
  • Peoples Bank (Kansas)'s Biogen position peaked at $7.76K in Q4 2023.
  • 876 funds tracked by Wall St. Rank held Biogen as of Q4 2024.

Based on Peoples Bank (Kansas)'s 13F filing for Q4 2024, filed 8 Jan 2025.